https://orcid.org/0000-0001-7952-1340
References
- GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021.
- Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/s0140-6736(18)30841-9
- Soriano JB, Abajobir AA, Abate KH; GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/s2213-2600(17)30293-x
- Li W, Luo W. Current status of prevention and treatment of chronic respiratory diseases in China. Med J West China. 2020;32(01):1–4.
- Zhong N. Early diagnosis and early intervention should be the main research direction of prevention and treatment of COPD in China. Chin J Tuberc Respir Dis. 2012. doi:10.3760/cma.j.issn.1001-0939.2012.04.002
- Alan K, Mike T. Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017;26:143.
- Li Z, Zhang X, Song X, Li H, Chen Y, Qin Z. Interpretation of the 2020 GOLD’s global strategy for prevention, diagnosis and management of COPD(I): pharmacological treatment of stable COPD. Chin Gen Pract. 2021;24(8):923–929. doi:10.12114/j.issn.1007-9572.2021.00.155
- Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17(12):1645–1651. doi:10.5588/ijtld.12.0995
- Chinese Medical Association. Guideline for primary care of chronic obstructive pulmonary disease. Chin J Gen Pract. 2018;17(11):856–870. doi:10.3760/cma.j.issn.1671-7368.2018.11.002
- Yawn BP, Martinez FJ. POINT: can screening for COPD improve outcomes? Yes. Chest. 2020;157(1):7–9. doi:10.1016/j.chest.2019.05.034
- Chilvers ER, Lomas DA. Diagnosing COPD in non-smokers: splitting not lumping. Thorax. 2010;65(6):465–466. doi:10.1136/thx.2009.128421
- Han MK, Steenrod AW, Bacci ED, et al. Identifying patients with undiagnosed COPD in primary care settings: insight from screening tools and epidemiologic studies. Chronic Obstr Pulm Dis. 2015;2(2):103–121. doi:10.15326/jcopdf.2.2.2014.0152
- Yawn BP, Mapel DW, Mannino DM, et al. Development of the lung function questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5(1):1–10.
- Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95. doi:10.1080/15412550801940721
- Siu AL, Bibbins-Domingo K, Grossman DC, et al; US Preventive Services Task Force (USPST). Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(13):1372–1377. doi:10.1001/jama.2016.2638
- Inoue H, Tsukuya G, Samukawa T, et al. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2016;11:1903–1909. doi:10.2147/COPD.S110429
- Zhou J, Yu N, Li X, Wang W. Accuracy of six chronic obstructive pulmonary disease screening questionnaires in the Chinese population. Int J Chron Obstruct Pulmon Dis. 2022;17:317–327. doi:10.2147/COPD.S341648
- Respiratory Disease Branch of Chinese Medical Association Lung Function Professional Group. Guidelines for Pulmonary function examination (part II)-spirometer examination. Chin J Tuberc Respir Dis. 2014;37(7):481–486. doi:10.3760/cma.j.issn.1001-0939.2014.07.001
- Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5(1):11–18. doi:10.3348/kjr.2004.5.1.11
- Ouyang Y, Du W, Zhang B. [Application of ROC curve in non-communicable diseases screening]. Chin J Prevent Med. 2015;49(4):401–404. Chinese.
- Li J, Feng R, Cui Y, Liu S, Zeng Z, Wang X. Analysis on the affordability and economic risk for using medicine to treat patients with chronic obstructive pulmonary disease in tier 3 hospitals in China. Chin Health Econ. 2015;34(9):66–68.
- Li J, Wang L, Yu R, Mao J, Zhou F, Wang B. Cognitive survey of knowledge related to chronic obstructive pulmonary disease and pulmonary rehabilitation in general practitioners in Xuhui District. Shanghai. Shanghai Med Pharm J. 2021;42(6):7–11.
- Respiratory Branch of Shanghai Medical Association Grassroots Respiratory disease Prevention alliance. Questionnaire survey on the knowledge of pulmonary functions in general physicians in Shanghai. Chin J Respir Crit Care Med. 2018. doi:10.1097/CCM.0000000000003138
- Anzueto A, Miravitlles M. Tiotropium in chronic obstructive pulmonary disease - A review of clinical development. Respir Res. 2020;21(1):199. doi:10.1186/s12931-020-01407-y
- Yi G, Jingping Z. Develop standardized lung function training to help prevent and control chronic respiratory diseases. Chin J Pract Intern Med. 2019;39(5):481–484. doi:10.19538/j.nk2019050101
- Tsukuya G, Matsumoto K, Fukuyama S, et al. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study. Allergol Int. 2015;64(1):49–53. doi:10.1016/j.alit.2014.06.002
- Yao Y, Tian H, Wu F, et al. Validation of the chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) used in community setting. Acad J Guangzhou Med Coll. 2021;49(3):41–46.
- Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST